Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategy
STE logo

STERIS Revenues Surge 13.3% to $5.14B Amid Acquisitions and Segment Strength

STE10-KFiling Date: 5/29/2024
STERIS plc
Description

What this story covers

STERIS plc reported 5 point 14 billion dollars in fiscal 2024 revenues, up 13 point 3 percent, driven by Healthcare growth from BD acquisition and pricing. Operating income rose 5 point 7 percent to 836 million dollars; recurring revenues hit 74 point 7 percent. Strong liquidity with 973 million dollars operating cash flow supports expansions. Divestiture of Dental segment refines focus on infection prevention core.

Story snapshot

CompanySTERIS plc
TickerSTE
VariantStandard detailed
Duration22:38
Filing type10-K
PeriodAnnual 2024
IndustryHealthcare & Pharmaceuticals
Accession0001757898-24-000008

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in